Association of Beta Blocker Use with Depressive Outcomes
NCT06743633 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1136
Last updated 2024-12-20
Summary
An Observational Study to Explore the Association Between β-Blocker Use and Depressive Outcomes
Conditions
- Depression - Major Depressive Disorder
Sponsors & Collaborators
-
Chitkara University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-01-01
- Primary Completion
- 2025-04-30
- Completion
- 2025-05-31
More Related Trials
-
The Impact of Depression and/or Anxiety on PCI Patients
NCT03057691 ·Status: UNKNOWN
-
Lipopolysaccharide (LPS) Challenge in Depression
NCT03142919 ·Status: COMPLETED ·Phase: PHASE1
-
NMDA Modulation in Major Depressive Disorder in Late- Life
NCT03414931 ·Status: COMPLETED ·Phase: PHASE2
-
Burst Suppression Anesthesia for Treatment of Severe Depression
NCT02935647 ·Status: COMPLETED ·Phase: PHASE1
-
DPA-714 and FDG PET/MRI in Depression
NCT06565936 ·Status: RECRUITING ·Phase: NA
-
Prediction of Antidepressant Treatment Response Using Machine Learning Classification Analysis
NCT02330679 ·Status: UNKNOWN ·Phase: PHASE4
-
Acupuncture in Depression: From the Clinical Trial, Biomarkers to Molecular Biology
NCT03452384 ·Status: COMPLETED ·Phase: NA
-
Components of Placebo Effects in Sadness
NCT03507959 ·Status: COMPLETED ·Phase: NA
-
A Neuroimaging Study of Open-label Placebo in Depressed Adolescents
NCT04201106 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Sensor-based Characterization of Depression
NCT04370002 ·Status: RECRUITING
-
Cognitive Training for Depression II
NCT01934491 ·Status: COMPLETED ·Phase: NA
-
The Effect of Patient Cost-Sharing on Antidepressant and Adjunctive Therapy Use
NCT01141400 ·Status: COMPLETED
-
Glabellar Botulinum Toxin Injections for the Treatment of Geriatric Depression
NCT03833063 ·Status: WITHDRAWN ·Phase: PHASE1
-
Stepped Care for Depression and Musculoskeletal Pain
NCT00118430 ·Status: COMPLETED ·Phase: PHASE4
-
Methylation Status of BDNF Gene After Dialectical Behavior Therapy in BPD
NCT02134223 ·Status: COMPLETED ·Phase: NA
-
Functional and Metabolic Changes in the Course of Antidepressive Treatment
NCT02099630 ·Status: COMPLETED
-
Depression, Genes, Cytokines, Chronic Fatigue, Physical Illnesses and Quality of Life
NCT02943330 ·Status: COMPLETED
-
Oxygen Therapy in Depression
NCT02149563 ·Status: UNKNOWN ·Phase: NA
-
Improve the Quality of Life After a Hospitalization in Critical Care
NCT02762409 ·Status: COMPLETED
-
Brain Imaging in Depression
NCT00050700 ·Status: COMPLETED
-
Adjunctive Bright Light Therapy in Patients With Bipolar Depression and Eveningness
NCT05357313 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Effect of Attention Bias Modification Training on Reducing Depressive Symptoms
NCT01628016 ·Status: COMPLETED ·Phase: NA
-
Schema Therapy for Chronic Depression
NCT03084744 ·Status: UNKNOWN ·Phase: NA
-
Treatment for Post-Stroke Depression
NCT00029172 ·Status: COMPLETED ·Phase: PHASE4
-
Patient Dimensions as Predictors of Varied Treatment Responses and Outcomes in Patients With Major Depression
NCT00744406 ·Status: COMPLETED ·Phase: PHASE2